Atypical scrapie isolates involve a uniform prion species with a complex molecular signature by Götte, Dorothea et al.
Atypical Scrapie Isolates Involve a Uniform Prion Species
with a Complex Molecular Signature
Dorothea R. Go¨tte1, Sylvie L. Benestad2, Hubert Laude3, Andreas Zurbriggen1, Anna Oevermann1.,
Torsten Seuberlich1*.
1NeuroCentre, National and OIE Reference Laboratories for BSE and Scrapie, Division of Experimental Clinical Research, Vetsuisse Faculty, University of Berne, Berne,
Switzerland, 2Department of Pathology, Norwegian Veterinary Institute, Oslo, Norway, 3 3U892 Virologie Immunologie Mole´culaires, Institut National de la Recherche
Agronomique, Jouy-en-Josas, France
Abstract
The pathobiology of atypical scrapie, a prion disease affecting sheep and goats, is still poorly understood. In a previous
study, we demonstrated that atypical scrapie affecting small ruminants in Switzerland differs in the neuroanatomical
distribution of the pathological prion protein (PrPd). To investigate whether these differences depend on host-related vs.
pathogen-related factors, we transmitted atypical scrapie to transgenic mice over-expressing the ovine prion protein
(tg338). The clinical, neuropathological, and molecular phenotype of tg338 mice is similar between mice carrying the Swiss
atypical scrapie isolates and the Nor98, an atypical scrapie isolate from Norway. Together with published data, our results
suggest that atypical scrapie is caused by a uniform type of prion, and that the observed phenotypic differences in small
ruminants are likely host-dependant. Strikingly, by using a refined SDS-PAGE technique, we established that the prominent
proteinase K-resistant prion protein fragment in atypical scrapie consists of two separate, unglycosylated peptides with
molecular masses of roughly 5 and 8 kDa. These findings show similarities to those for other prion diseases in animals and
humans, and lay the groundwork for future comparative research.
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Introduction
Transmissible spongiform encephalopathies (TSEs), such as
scrapie in sheep and goats, bovine spongiform encephalopathy
(BSE) in cattle, and Creutzfeldt-Jakob disease (CJD) in humans,
are fatal neurodegenerative diseases that are caused by prions,
which are infectious misfolded proteins [1]. The neuropathology
of the TSEs includes spongiform vacuolation, gliosis, and the
aggregation of a pathological isoform, PrPd, of the endogenous
host prion protein, PrPc, in the brain. According to the protein-
only hypothesis, the PrPd isoform is the infectious agent [2]. PrPd
differs biochemically from PrPc in a number of its characteristics,
which include the partial resistance to proteolytic degradation by
proteinase K (PK). PK-resistant PrPd fragments (PrPres) can be
detected via immunochemical techniques such as Western blotting
(WB) [3].
To date, three types of TSE have been found in small
ruminants: classical scrapie, BSE, and atypical scrapie. Classical
scrapie has been observed for more than two centuries [4].
Classical scrapie prions are transmitted between animals and via
contamination of the environment, and may cause significant
losses in affected small ruminant flocks. Experimentally, sheep and
goats are susceptible to oral infection with BSE prions [5] and,
recently, two goats have been described that were likely to have
been naturally infected in the course of a BSE epidemic in cattle in
Europe [6,7]. For this reason, TSEs in small ruminants have been
intensively monitored in European Union member states,
however, to date, no further small ruminant BSE cases have been
identified. Atypical scrapie was first observed in Norway in 1998
(hence, Nor98) and was later detected in a number of other
countries primarily by means of active disease surveillance
schemes [8,9]. Such cases revealed discordant phenotypic features,
in particular, SDS-PAGE PrPres banding patterns and neuroan-
atomical PrPd distributions that differ from those of classical
scrapie and BSE. Moreover, these distinctions were frequently
found in sheep that displayed prion protein genotypes associated
with a relative resistance to classical scrapie, and there was rarely
more than one animal per herd affected [10,11].
Upon transmission into sheep and rodents models in the
laboratory, this distinct phenotype was preserved, and it was
concluded that atypical scrapie cases are caused by prion species
different from those that underlie classical scrapie and BSE [12–
16]. However, the pathobiology and phenotypic diversity of
naturally occurring atypical scrapie remain to be elucidated. This
lack of clarity results partly from the limited brain tissue available
to researchers via active disease surveillance programs.
In a previous study, we had access to whole brains from small
ruminants affected with atypical scrapie, and discovered a marked
diversity in the neuroanatomical distribution of the PrPd ([17],
table 1). Similar findings were later reported by other groups in
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both naturally-occurring cases and following experimental oral
transmission of atypical scrapie isolates to sheep [16,18–20].
However, it remains to be determined whether this diversity in
PrPd distribution is attributable to host factors, the involvement of
particular prion types or a combination of both.
In the current report, we have addressed this question by
transmitting a panel of eight small ruminant atypical scrapie
isolates, with different neuroanatomical PrPd distribution patterns,
into mice overexpressing the ovine prion protein. This mouse
model has been shown to be highly susceptible to both classical
and atypical scrapie prion pathology. We compared survival times,
pathology attack rates, patterns of lesions, PrPd distribution in the
brain, and biochemical PrPres characteristics between these
different groups and with mice infected with isolates of classical
scrapie and atypical/Nor98 scrapie. Our findings support that
atypical scrapie, despite the phenotypic variations evident in the
natural hosts, is caused by a uniform species of prion. Our
characterization of atypical scrapie isolates also reveals a
previously unrecognized complexity of the molecular PrPres
phenotype.
Results
Clinical signs of disease, attack rates and survival times
Following inoculation with atypical/Nor98 and classical scrapie,
mice consistently showed characteristic clinical signs of TSE. At
the terminal stage of the disease, the animals displayed ataxia and
tremor, lost weight, and exhibited impaired grooming behavior
and kyphosis. There were no obvious differences in clinical
presentation between the isolates studied. As some of the sham-
inoculated mice also showed neurological impairment at the end
of their life-span, we defined mice as TSE positive or negative
according to the presence or absence of PrPd in the brain in either
immunohistochemistry (IHC) or WB. All eight Swiss atypical
scrapie isolates, two derived from goats and six from sheep, and
the Nor98 isolate transmitted efficiently to tg338 mice following
intracerebral inoculation, with attack rates of 100% (Table 1).
The average survival times in the atypical scrapie groups including
the Nor98 were very similar (between 188 and 235 days) and did
not differ significantly between groups that were infected with
isolates from donor animals of different PRNP genotypes.
However, inoculation survival in all atypical scrapie isolates and
Nor98 was significantly shorter (p,0.0001) compared to the
classical scrapie isolate (304617 days) and to the sham-inoculated
mice (567622 days (Fig. 1)).
Table 1. Small ruminant isolates, attack rates, and survival times in tg338 mice.#
Inocula Species
PrPd deposition intensity"
[Obx/Cbl/Cbr] PRNP Genotype1
Attack rate
[Nd/Ni]
Mean survival time
± SEM [days]
Atypical scrapie
G1/RS Goat 1/-/- A136L141H154Q171/ALHQ 17/17 23566.5
G2/FS Goat 1/1/3 ALHQ/ALHQ 14/14 20565.0
S2/RS Sheep 1/3/- ALRR/ALRR 12/12 18864.8
S3/RS Sheep 1/3/- ALRR/ALRR 16/16 22764.2
S4/RS Sheep 1/-/- ALHQ/ALHQ 2/2* 189/256
S5/FS Sheep 1/1/3 ALRQ/ALHQ 16/16 21666.0
S6/FS Sheep 0/3/0 ALRR/ALRR 14/14 21366.0
S7/CS Sheep 1/3/3 AFRQ/AFRQ 14/14 21565.2
Nor98 Sheep 1/3/3 ALHQ/ALHQ 16/16 22363.9
Classical scrapie
Classical scrapie Sheep 3/2/3 V136R154Q171/A136R154Q171 16/16 304617
Negative
Sham-inoculated Sheep n.a. 0/18 567622.4
#abbreviations: Obx, obex; cbl, cerebellum; Cbr, cerebrum; n.a. not available; Ni, number of mice inoculated; Nd, number of mice diseased
"as reported in our previous study [17]; -, structure missing; 1, mild; 2, moderate; 3, severe.
*for S4/RS fourteen out of sixteen inoculated mice died within two days post inoculation, most probably due to a high bacterial contamination of the sample.
1polymorphisms of the PRNP alleles are shown for position 136, 141,154 and 171 for the atypical scrapie isolates and for positions 136, 154 and 171 for the classical
scrapie control. Alleles associated with relative susceptibility with atypical scrapie are indicated in bold.
doi:10.1371/journal.pone.0027510.t001
Figure 1. Survival of tg338 mice inoculated with different TSE
isolates. Mice infected with Swiss atypical scrapie isolates (red) showed
survival times similar to those infected with Nor98 (black), but these
survival times were clearly shorter compared to the classical scrapie
group (blue) and sham-inoculated mice (grey).
doi:10.1371/journal.pone.0027510.g001
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Histopathological brain lesion profiles
The intensity and neuroanatomical distribution of vacuolar
lesions are very similar between mice infected with sheep (Fig. 2A)
vs. goat (Fig. 2B) atypical scrapie isolates, and the Nor98 isolate.
However, in the corpus callosum, a slight difference in the
intensity of lesions is observed between mice infected with the
Swiss atypical sheep isolates (Fig. 3B) and those with the Nor98
isolate (Fig. 2A). In addition, inoculation with the goat isolate G1/
RS results in lesion scores similar to the Nor98 isolate (Fig. 2B),
while the inoculation with the sheep isolate S4/RS results in
intermediate lesion scores (Fig. 2A) in the corpus callosum.
Vacuolar lesions were, in general, less severe following inoculation
with the classical scrapie isolate, although the hypothalamus still
exhibited considerable lesions in these mice (Fig. 2C, Fig. 3A). In
both, sham- and non-inoculated mice, we observed mild vacuolar
lesions in most of the brain structures investigated, and lesions
were particularly notable in the white matter of the cerebellum
(Fig. 2D, Fig. 3C).
Neuroanatomical PrPd distribution
We assessed the distribution of the pathological PrPd protein at
four rostro-caudal positions in the brains of inoculated mice (Fig.
S1A). The distribution pattern of PrPd immunoreactivity is similar
amongst the mice inoculated with the Swiss atypical scrapie
isolates as well as the Nor98 isolate. However, the PrPd
distribution in these groups is strikingly distinct from that observed
in the classical scrapie-inoculated mice (Figs. 4, S1B). The
localization and size of plaque-like PrPd deposits also differ greatly
between the groups exposed to atypical vs. classical scrapie isolates
(Fig. 5). These plaques are readily observable in hematoxylin and
eosin-stained sections from mice inoculated to classical, but not
atypical scrapie (Fig. 3A). In sham-inoculated mice, we observed a
faint intraneuronal labeling in the cortex, the septal nuclei, and in
some white matter structures, as well as a faint axonal staining in
the thalamic nuclei (Figs. 4, S1B), the latter was also evident in
non-inoculated tg338 mice (data not shown).
Biochemical characteristics of PrPres following
transmission to tg338 mice
We used Western blotting to characterize the SDS-PAGE
banding patterns of PrPres using our standard monoclonal
antibody P4-based protocol [17] and 16.5% polyacrylamide gels.
As expected, the PrPres WB patterns in the brains of the inoculated
mice were similar with those previously published for classical and
atypical scrapie, and consistent with the respective inocula.
However, we identified an additional PrPres fragment with a
molecular mass ,6.5 kDa in some immunoblots from mice
inoculated with the atypical/Nor98 scrapie isolates (Fig. 6A). We
then re-analyzed all the samples using 4-20% gradient tris-glycine
polyacrylamide gels to better separate the low molecular mass
proteins. These immunoblots were also probed with the P4
antibody and we found that all of the atypical scrapie samples,
including the Nor98, showed the same pattern, with two distinct
bands of lower molecular mass; one migrating at roughly 5 kDa,
and another band at 8 kDa (Figs. 6B and S2). No bands were
detected in the Western blot, when the P4 antibody was replaced
by IgG purified from normal mouse serum (data not shown).
Sham-inoculated and non-inoculated control mice also showed
some discrete PK-resistant bands in the Western blot. The bands
were, in general, much less intense, visible only upon loading of
relative large amounts of material and were not detected following
more stringent PK-digestion (Fig. S3). However, in the majority
of the sham-inoculated and non-inoculated mice we found an
8 kDa band of a relative high PK-resistance, which was
reminiscent to that in the atypical scrapie infected mice (Figs. 6
B-E and S3).
Immunoblots containing representative atypical scrapie samples
were then probed with the monoclonal Sha31 antibody, which is
widely used in small ruminant TSE research and diagnostics and
binds nearer to the C-terminus of the prion peptide than does P4
or the 9A2 antibody. After immunoblotting with Sha31, however,
only the 8 kDa, but not the 5 kDa moiety of PrPres could be
detected (Fig. 6C). We then treated the protein lysates with the
endoglycosidase PNGase F, which removes N-linked glycosylation.
Treatment with PNGase F indicated that the fragments migrating
at 5 kDa, 8 kDa, and 18 kDa correspond to unglycosylated PrPres
moieties, whereas those above 18 kDa are N-linked glycosylated.
We found that immunoblotting with the 9A2 antibody resulted in
the same pattern as P4, confirming the identity of these bands as
PrPres fragments (Fig. 6D and E). While the ,18 kDa PrPres
fragment and its glycoforms were relatively sensitive to more
stringent PK-digestion, this was not the case for the 5 and 8 kDa
peptides (Fig. 6F).
Biochemical PrPres characterization of sheep/goat isolates
We then investigated whether the low molecular mass dual-
banding-pattern observed in mice inoculated with atypical scrapie
was relevant to atypical scrapie in small ruminants. To this end, we
used 4–20% gradient SDS-PAGE to analyze protein lysates
obtained from the sheep and goat tissue used to prepare the
atypical scrapie inocula. Interestingly, we found that the banding
patterns obtained from immunoblotting with P4 in the atypical
sheep and goat scrapie samples greatly resemble those obtained
from atypical scrapie-inoculated tg338 mice. Similar to the
findings with the inoculated tg338 mice, the 8 kDa peptide, but
not the 5 kDa peptide, was detected using Sha31 (Fig. 7).
Noteworthy, neither the 8 kDa peptide nor other PK-resistant
bands were observed in TSE negative sheep (Figs. 7 and S3B).
These results suggest that, in the natural host, both the 5 kDa and
8 kDa peptides are disease-specific, and that these fragments are
C-terminally truncated to a different extent.
Discussion
The current study seeks to delineate the host-related from the
pathogen-related factors that affect the phenotype of atypical
scrapie in small ruminants. We show that the transmission of a
panel of defined atypical scrapie isolates from sheep and goats in
Switzerland, which displayed distinct neuroanatomical PrPd
deposition patterns in the donor animals, resulted in a uniform
disease phenotype in tg338 mice with respect to attack rates,
survival times, PrPd distribution, and the molecular pattern of the
PrPres peptides. Taken together, the overall phenotype of the Swiss
atypical scrapie isolates was indistinguishable from that of the
Nor98, but was clearly distinct from that of the classical scrapie
isolate. Our data therefore corroborate previous findings that
atypical scrapie involves a prion species distinct from those of
classical scrapie. Moreover, our results indicate that the type of
prion is identical in both the Nor98 isolate and the atypical scrapie
cases presented in this work.
In our analysis of the severity and distribution of brain lesions,
we observed some subtle differences between the various isolates.
However, these differences fell within the range of the variability
observed between individual mice within each isolate group, and
are therefore not considered significant. An unexpected observa-
tion was that non-inoculated mice as well as sham-inoculated mice
also displayed mild histopathological lesions and PrP immunore-
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activity. In the latter, this was complemented by neurological
impairment at advanced age (i.e., 570 days post-inoculation) in
some animals. These findings could be due to aging, sanitary status
of the mouse colony or the housing conditions. Also, we cannot
completely rule out that the negative inoculum contained low-
levels of prion infectivity. While this situation may hamper the
interpretation of data when investigating prion isolates that reveal
longer incubation periods, it does not impact on our ability to
interpret the range of data produced with the atypical and classical
scrapie isolates in the present study.
The phenotype of the Swiss atypical scrapie isolates in the tg338
model is strikingly similar to previously published data on
atypical/Nor98 scrapie field isolates from Germany, Norway,
France, and the UK that used both the tg338 mouse model as well
Figure 2. Lesion profiles in scrapie-infected tg338 mice. Lesions were scored according to the protocol established by Fraser and Dickinson
[39] in ten grey matter areas (left y-axis, scale 0 to 5) and in four white matter areas (right y-axis, scale 0 to 3). All depicted values represent means of
scores in mice inoculated with the same isolate: atypical sheep scrapie (A), atypical goat scrapie (B), classical scrapie (C) as well as sham-inculated
and non-inoculated mice (D). To facilitate cross-comparison, Nor98 scores are included in each graph.
doi:10.1371/journal.pone.0027510.g002
Figure 3. Representative spongiform pathology in tg338 mouse brains. (A) Vacuolar lesions are evident in the hypothalamus,
hippocampus, corpus callosum, and cerebral peduncle of TSE-inoculated and control mice. Classical scrapie-inoculated mice exhibit plaques in
various brain structures such as the hippocampus (star). (B) Variability of spongiform lesions in the corpus callosum between mice inoculated with
atypical scrapie isolates. (C) Cerebellum of a non-inoculated mouse showing mild (left) and a sham-inoculated mouse showing severe (right) vacuolar
lesions. All microphotographs are 40X magnifications of hematoxylin and eosin-stained mouse brain sections.
doi:10.1371/journal.pone.0027510.g003
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as other ovine PrP transgenic mouse lines [21–23]. This suggests
that there are no major differences between atypical scrapie prions
isolated from various geographical origins and from sheep or
goats. Arsac and collaborators [12] reported that atypical scrapie
isolates from donor animals carrying PRNP alleles that were
associated with a relative higher susceptibility to the disease
(AF141RQ or AHQ) revealed a significantly shorter survival time
compared to those derived from donor animals without such
alleles in mice transgenic for the ovine ARQ PRNP allele. In our
and others studies [13,22] a similar effect for atypical scrapie
isolates was not observed in tg338 mice, which may be related to
higher PrP expression levels and/or more rapid evolution of the
disease in this model. Our results thus provide indirect evidence
that the observed variability in the neuroanatomical PrPd
distribution of atypical/Nor98 scrapie amongst small ruminants
may result from, as yet unidentified, host factors rather than from
the involvement of distinct prion agents. This situation contrasts
sharply to that in classical scrapie, for which a large body of
evidence points towards the existence of diverse prion strains,
which differ in their phenotypic presentation in sheep and after
transmission to mouse models [24–26]. It is conceivable that this
strain diversity, as in other infectious diseases, results from serial
transmission events and interactions with the host. In this respect,
the classical scrapie isolate used in our study may not fully
represent this class of TSE agents. However, the uniformity of the
atypical scrapie isolates in the tg338 model, further questions the
origin of this disease. Therefore, more data from transmission
studies in small ruminants will be required to thoroughly
characterize the etiology, pathogenesis and host-pathogen inter-
action in atypical scrapie.
Figure 4. Neuroanatomical PrPd distribution in mice inoculated with different scrapie isolates. Microphotographs of representative
mouse brain sections stained for PrPd by immunohistochemistry using antibody SAF84 are presented. For details on the anatomical structures, see
Fig S1.
doi:10.1371/journal.pone.0027510.g004
Prion Signature of Atypical Scrapie
PLoS ONE | www.plosone.org 6 November 2011 | Volume 6 | Issue 11 | e27510
The molecular PrPres phenotypes in small ruminants and mice
affected with atypical/Nor98 scrapie have been addressed in detail
in a series of studies [12,22,27–30]. In these studies there is some
disagreement regarding the estimated molecular mass of the
prominent PrPres band of lower molecular mass (,7–12 kDa),
which is most likely due to different electrophoretic conditions.
However, this band is universally considered to represent a single
truncated PrPres fragment. Using gradient SDS-PAGE and a set of
PrP-specific monoclonal antibodies, we now show that this band in
fact involves two distinct PrPres fragments of approximately 8 kDa
and 5 kDa. This dual-banding-pattern has likely been overlooked
in the past, since to our knowledge all studies that focused on the
molecular PrPres properties in atypical scrapie used 12-15% SDS
PAGE, which do not resolve the 5 and 8 kDa peptides. Moreover,
confirmatory Western blot techniques may miss the 5 kDa
fragment, when relying on antibodies that bind to the center of
the PrPres (,aminoacid 150), such as Sha31.
We detected the 8 kDa PrPres peptide in atypical/Nor98
scrapie-affected tg338 mice, sheep, and goats using the P4, 9A2,
and Sha31 antibodies, indicating that this fragment includes at
least amino acids 93 to 155 of the full-length mature prion protein.
This band was detectable with a much lower signal in negative
control mice, and exhibited a high resistance to proteolysis.
However, the 8 kDa PrPres band was absent in TSE-negative
sheep and clearly related to the atypical scrapie affected sheep and
goats. This could be due to the over-expression of the ovine prion
protein transgene in these mice, and may explain the relatively
high susceptibility of these mice to atypical scrapie compared to
Figure 5. Localization and size of plaque-like PrP deposits in atypical and classical scrapie. In atypical scrapie-inoculated mice, relatively
small plaques were observed in the neuropil (40X magnification), while the plaques in the classical scrapie-inoculated mice were larger, coalescing
and always associated to the leptomeninges and the ependyma (20X magnification). PrPd immunoreactivity was detected using the mAb SAF84.
Neuroanatomical structures: septal nuclei (se), caudate putamen (pu), lateral ventricle (lv) and thalamus (th).
doi:10.1371/journal.pone.0027510.g005
Figure 6. Molecular PrPres typing of atypical scrapie affected tg338 mice. Western blots for PrPres of representative brain extracts following
SDS-PAGE using (A) 16.5% tris-glycine and (B-F) 4–20% tris-glycine gradient gels. Immunochemical detection was performed with antibodies P4,
Sha31 or 9A2 as indicated. In some instances (D, E), samples were deglycosylated with PNGaseF. (F) Atypical scrapie PrPres banding pattern following
sample pretreatment with different concentrations of proteinase K (PK, in mg/ml), compared to the PK digestion protocol of the Bio-Rad TeSeE
confirmatory Western blot (BR). Identification codes for the atypical scrapie isolates are shown at the top. Controls: cl, classical scrapie affected tg338
mouse; non-inoc, non-inoculated tg 338 mouse; neg s, TSE negative sheep. Molecular mass standards in kDa and loaded tissue equivalents are
indicated.
doi:10.1371/journal.pone.0027510.g006
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other TSEs. In contrast, the 5 kDa PrPres species was observed
only in atypical scrapie-affected tg338 mice and small ruminants,
but not in the negative control mice and healthy small ruminants.
The 5 kDa peptide also did not react with the more C-terminal-
directed Sha31 antibody, and thus differs from the 8 kDa PrPres at
its C-terminus.
Recently, we reported on a classical scrapie outbreak in a Greek
goat flock, in which several animals exhibited a distinct C- and N-
terminally ragged PK-resistant PrPres fragment [31]. This peptide
demonstrated the same antibody-binding properties, and was
estimated to be at similar molecular mass as the 5 kDa PrPres
moiety described in the present study. At that time, it was unclear as
to which type of prion disease this peptide was related. Our current
findings support the idea that this fragment is related to atypical vs.
classical scrapie, and that both prion species were present in the
Greek flock. Future studies will conduct a direct comparison of these
peptides by gradient SDS-PAGE, pending the receipt of material
from mouse transmission studies of the Greek isolates.
PrPres peptides of low molecular mass have also been described
in other types of prion disease, such as Gerstmann-Stra¨ussler-
Scheinker disease [32,33] and Creutzfeldt-Jakob disease [34,35] in
humans as well as in H-BSE in cattle [36,37]. Forthcoming
directions of research are likely to focus on more precise
comparative analyses of truncated PrPres peptides and their role
in the biology of human and animal prion diseases.
Materials and Methods
TSE isolates
A total of eight atypical scrapie isolates from Switzerland
[13,17] were included in this study, all of which had been
identified by active or passive surveillance for TSEs in small
ruminants in the years 2004 and 2005. An atypical scrapie isolate
from Norway (Nor98), a classical scrapie isolate from an
experimentally-infected sheep (genotype donor sheep VRQ/
VRQ; recipient VRQ/ARQ). A pool of medulla oblongata tissues
from sheep that tested negative for TSEs by two independent TSE
screening tests, and by immunohistochemistry (IHC) in different
brain structures and lymphatic tissues, served as a sham-inoculum.
Details on the isolates and controls are shown in Table 1.
Transgenic mice and bioassays
Tg338 mice express the ovine VRQ PrP on a murine PrP
knock-out background at 6- to 8-fold higher levels compared to
sheep [13,38]. Tg338 mice were imported from a specific-
pathogen-free (SPF) holding facility and bred in-house in a
biosafety level 3 and SPF environment. Groups of 16 to 20 tg338
mice per isolate (8 to 10 weeks of age) were inoculated
intracerebrally (ic) with 20 ml of 10% [w/v] brain tissue
homogenates under isoflurane anesthesia. Mice were monitored
for clinical signs of TSE at least twice per week, and were
sacrificed when clinical signs were observed that indicated end-
stage TSE, or when a minimum survival time of 630 days had
elapsed. At necropsy, the brain of every second animal was fixed in
formalin for histopathology and immunohistochemistry. The
remaining brains and the spleen and muscle tissues were snap-
frozen in liquid nitrogen and stored at -20uC for western blot and
ELISA analyses. Parallel samples were obtained from non-
inoculated mice of variable age that had served for breeding
purposes (n = 11). A mouse was considered to be TSE-positive
when PrPd was detected by Western blotting or immunohisto-
chemistry in brain samples.
Ethics statement
All animal experiments were conducted according to the
‘‘Ethical Principles and Guidelines for Experiments on Animals’’
by the Swiss Academy of Medical Sciences and were approved by
the Committee for Animal Experiments of the Canton of Berne
(license #10/08).
Histopathology and lesion profiles
Mouse brains were fixed in 4% formaldehyde, decontaminated
for 1 h in formic acid (98%) at room temperature, cut transversely
into five pieces as suggested by Fraser and Dickinson [39], and
embedded in paraffin. Four-mm thick tissue sections were stained
with hematoxylin and eosin and vacuolar lesions were scored in
ten defined grey matter areas on a scale from 0 to 5, and in four
white matter areas on a scale from 0 to 3 [40].
Immunohistochemistry for PrPd
The PrPd immunohistochemistry was performed on the same
brain structures used for the lesion profiling, with a NEXEX robot
(Ventana instruments) and monoclonal SAF84 antibody (SPI bio,
A03208, 1:100) as described elsewhere [41], at the Institute of
Neuropathology, University of Zu¨rich. The PrPd deposition
pattern was assessed at the NeuroCentre by microscopic
Figure 7. Molecular PrPres typing of atypical scrapie-affected
sheep and goats. SDS-PAGE was performed using 4–20% gradient
gels and blots were probed with mAb P4 (A) and Sha31 (B). Samples of
a classical scrapie-affected sheep (cl) and a TSE-negative sheep (neg)
served as controls. Molecular mass standards and tissue equivalents are
indicated.
doi:10.1371/journal.pone.0027510.g007
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examination of at least six mice per isolate, with the exception of
isolate S4/RS, for which only one animal was available.
Western blotting
Whole brains from mice, and brain samples of donor sheep and
goats, were homogenized and purified using a commercial TSE test
kit (Bio-Rad, 355–1165) according to the manufacturer’s instruc-
tions, but with the following modification: the kit-provided PK of
unknown concentration was replaced by PK (Roche, 03115828001)
at a final concentration of 50 mg/ml, which corresponds to 250 mg
PK per gram wet tissue. The resulting pellets were resuspended in
La¨mmli sample buffer (Bio-Rad, 161–0737). PrPres fragments were
separated by SDS-PAGE in hand-cast 16.5% tris-glycine gels or in
pre-cast 4-20% gradient tris-glycine gels (Invitrogen, EC 6028),
transferred to PVDFmembranes (Bio-Rad, 162–0177), and blocked
with 1% casein in PBS (Bio-Rad, 161–0783). Three PrP-specific
mAbs were used: 9A2 (102WNK104)[42], P4 (93WGQGGSH99, r-
biopharm, R8007), and Sha31 (148YEDRYYRE155, Bio-Rad
TeSeE Western Blot, 355–1169). The epitopes on the prion protein
recognized by these mAbs have been schematically presented in a
previous study [31]. Immunoreactivity was detected using a
polyclonal rabbit anti-mouse HRP antibody (Dako, P0260), a
chemiluminescent detection system (ECL-plus Amersham Biosci-
ences), and a LAS 3000TM imaging system (Fuji Film, Fuji Inc,
Valhalla, NY). Protein bands were quantified and their molecular
mass calculated with Quantity One software (Bio-Rad, Version
4.6.2) in comparison with a molecular mass standard (See-Blue,
Invitrogen, LC5625).
Deglycosylation treatment
Following the resuspension of precipitated protein pellets in
TD4215 (4% [w/v] SDS, 2% [v/v] b-mercaptoethanol, 192 mM
Tris, 5% [w/v] sucrose), proteins were deglycosylated by
incubation with the endoglycosidase PNGase F for 90 min at
37uC (New England Biolabs, P0704L) according to the manufac-
turer’s instructions. Samples were mixed with an equal amount of
La¨mmli sample buffer and processed for western blotting as
described above.
Statistical analyses
Survival time was defined as the number of days from
inoculation to the animal’s death. Animals that died in the first
week following inoculation were excluded from the study. All
statistical analyses were carried out using GraphPad’s Prism
software (Version 5.03). Survival times were compared between
groups using the Log-rank Multiple-Comparison Test including
the Bonferroni-correction (p,0.000758).
Supporting Information
Figure S1 Scheme of the neuroanatomical PrPd distri-
bution in groups of tg338 mice inoculated with different
scrapie isolates. (A) Presentation of the neuroanatomical
structures investigated: cortex (cx), cingulum (cg), cerebral white
matter (cw), corpus callosum (cc), caudate putamen (pu), septal
nuclei (se), anterior commissure (ac), ventral pallidum (vp), piriform
cortex (pi), hypothalamus (ht), lateral ventricle (lv), hippocampus
(hi), hippocampal fissure (hf), habenula (ha), 3rd ventricle (3v),
thalamus (th), substantia nigra (sn), cerebral peduncle (cp), tractus
opticus (ot), amygdala (am), superior colliculus (sc), nucleus
brachium inferior colliculus (bi), pons (ps), aqueduct (aq), molecular
layer (ml), granular layer (gl), cerebellar roof nuclei (rn), cerebellar
white matter (wm), dorsal motor nucleus of the vagus nerve (dm),
nucleus hypoglossus (hy), 4th ventricle (4v), cerebellar peduncle (pe),
spinal tract nucleus of trigeminal nerve (tn), spinal tract nucleus of
trigeminal nerve (st), raphe (rf), pyramidal tract (pt). (B) PrPd is
depicted for mild (dots) and severe (filled areas) deposits in the grey
(red) and white matter (green) structures separately. Amyloid PrPd
plaques were observed in the neuropil (w) as well as in apparent
association with the cerebrospinal fluid space (q).
(TIF)
Figure S2 Quantitative analysis of the PrPres phenotype
in atypical scrapie affected tg338 mice. Molecular mass (y-
axis, 6SD) and relative quantities of PrPres bands (numbers [%] at
the right side of each dot) are depicted as means from at least five
mice per isolates following SDS-PAGE using 4–20% gradient gels
and monoclonal antibody P4.
(TIF)
Figure S3 Western blot banding patterns in the brains
of sham-inoculated mice. (A) Tg338 mice inoculated with
TSE-negative sheep brain show variable banding patterns after
treatment with PK (50 mg/ml). Survival times (in days) of
individual mice are indicated on the top. The picture on the left
shows an atypical scrapie affected mouse-brain sample (S7/CS) for
comparison. (B)The brain sample of a sham-inoculated mouse
(610 days post-inoculation [dpi]) was treated with different
concentrations of PK (indicated on top in mg/ml; BR: PK of the
Bio-Rad TeSeE Western Blot test kit of unknown concentration).
Upper bands of both mice are fully digested when using higher PK
concentrations whereas an 8 kDa band in sham-inoculated mice
are relatively PK-resistant. Controls: classical scrapie (cl), negative
sheep (neg s). Molecular mass markers are indicated at each side,
tissue equivalents loaded per well at the bottom.
(TIF)
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